GRZAN Philippine Medical Device Registration Services

1. Key takeaways

GRZAN provides the following services to Chinese medical device manufacturers entering the Philippine market. The scope is deliberately end-to-end: the licence-holding entity, the product certificates, the document legalisation chain and the post-market obligations are handled by one team, so that the registration certificate and the compliance system behind it are built together rather than in sequence by different parties.

2. Legal basis

Each module operates inside a defined instrument, and the scope of what we can do is set by those instruments rather than by commercial preference. Product certificates take one of two forms: the CMDN for Class A devices and the CMDR for Class B and C devices that fall outside the notification route, with the dossier built to ASEAN CSDT structure in the case of the CMDR. Where a device has already been approved by an ASEAN member state regulator under the AMDD-CSDT arrangement, the abridged route in FC No. 2022-008 applies, and our working target for that review stage is 30 working days.

The licence-holding layer is equally rule-bound. An importer or distributor LTO must be held by a Philippine entity, and the documentation attached to it includes the source list of authorised suppliers and clients together with the contract agreements, which are maintained as a standing register rather than assembled for the application. Certificates run for 5 years and require renewal, which is why the renewal module works to a 90-day window rather than to an expiry-date reminder. Post-market obligations under the PMAS framework attach to the MAH regardless of how light the original product dossier was, so the vigilance module is scoped by the products in the field rather than by the class of the certificate.

Document legalisation is a separate chain with its own rules. Following the Hague Convention between China and the Philippines, foreign public documents are legalised by notarisation plus Apostille rather than by consular legalisation, which shortens the path for the LOA, the CFS and the other supporting documents in a Philippine dossier. Getting this chain right at the start avoids the common situation in which the technical file is complete while the legalisation of a single certificate holds up the entire submission.

3. Expert insights

Insight 1: our own entity, not a subcontractor.

GRZAN operates its own subsidiary network in Southeast Asia, covering Singapore, Malaysia, Thailand, Indonesia, Vietnam and the Philippines. The licence-holding entity is our own, so control of the registration certificate is clear and does not depend on a third party’s cooperation. In practice this matters when timelines slip or when a commercial relationship changes: a certificate held through an unrelated local company is only as reliable as that company’s continued willingness to act.

Insight 2: the manufacturer keeps control.

We act as MAH but do not take part in distribution and do not compete with the manufacturer for margin. The manufacturer remains free to appoint or replace distributors, and the registration certificate does not become a bargaining chip in channel negotiations. This separation of the regulatory role from the commercial role is the structural point that distinguishes an independent MAH arrangement from one in which the licence holder is also the distributor.

Insight 3: we write our own regulatory content.

The 50 articles in this section were written by the GRZAN regulatory team on the basis of official regulatory documents verified as of 27 October 2026. We apply three-tier source grading, complete four-element legal citation, and do not fabricate market data. The same standard is applied to the projects we run, which is why the articles and the engagement work do not diverge in their conclusions.

Insight 4: regional coordination reduces cost.

If a product has already been approved in another ASEAN member state on a CSDT basis, the Philippines can use the abridged route, compressing the review stage from 180 days to about 30 working days. The saving is not only time: the same CSDT can be reused, so the marginal cost of adding the Philippine market to an existing regional registration is materially lower than starting from a blank dossier.

4. Practical recommendations

A typical Class B/C/D project follows the rhythm below. The stages overlap where the rules allow, and the LTO stage can run in parallel with dossier preparation.

The overall plan should assume 10 to 15 months on the standard route; the abridged route shortens it substantially. To start a project, we normally need the product technical file (or an existing CSDT or technical documentation), the ISO 13485 certificate, the CFS, samples of the product label and instructions for use, and the list of models to be filed. Where an ASEAN member state approval already exists, please provide the approval certificate together with the CSDT version that was filed at the time, because the abridged route depends on that record.

5. Verification checklist

• □ Licence-holding entity confirmed (own LTO, independent MAH arrangement)
• □ Pathway confirmed (CMDN for Class A; CMDR for Class B/C/D; abridged under FC No. 2022-008 where eligible)
• □ LTO documentation complete, including the source list and contract agreements
• □ Document legalisation chain planned (notarisation plus Apostille)
• □ PMAS obligations costed into the project (records, complaints, adverse events, FSCA)
• □ Renewal window scheduled at 90 days before the 5-year expiry
• □ Technical file, ISO 13485 certificate, CFS, labels and model list available

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including the Philippines. Our team prepares CMDN/CMDR dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the FDA Philippines, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com